Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis

EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021, Vol.9 (5), p.e03971-e03971
Main Authors: Kuhlman, Justin J, Alhaj Moustafa, Muhamad, Tun, Alexander J, Menke, David M, Tun, Han W, Jiang, Liuyan
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:EBV-positive HHV8-negative EBL is part of the spectrum of EBV-positive diffuse large B-cell lymphoma NOS. This entity can be labeled as primary age-related EBV-associated EBL and appears to respond well to rituximab and thoracentesis.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3971